fda approval of tirzepatide for weight loss approves (Zepbound) injection chronic management, with 72-week trials showing statistically significant body-weight reduction in adults with obesity or overweight FDA confirms tirzepatide shortage is
Pay in 4 interest-free payments of $5.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4


























